DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 2223--------------------------------------------------
       Ocrevus the first-line DMT for RRMS among neurologists surveyed
       By: agate Date: September 21, 2018, 11:18 am
       ---------------------------------------------------------
       It's clear from this article in Multiple Sclerosis News Today
       (September 21, 2018) that the drug companies are keenly aware
       that those with SPMS represent a largely untapped potential
       market and are trying hard to find something to offer.  It's
       also clear that the success Ocrevus is currently enjoying seems
       to be at least partly due to the extensive marketing campaign to
       promote it for very early treatment of MS.
  HTML https://multiplesclerosisnewstoday.com/2018/09/21/ocrevus-climbs-as-first-line-dmt-for-rrms-among-neurologists-surveyed-in-spherix-report/
       *****************************************************